Bonnie L Bassler is Director of REGENERON PHARMACEUTICALS, INC.. Currently has a direct ownership of 1,382 shares of REGN, which is worth approximately $1.56 Million. The most recent transaction as insider was on Aug 15, 2024, when has been sold 756 shares (Common Stock) at a price of $1170.0 per share, resulting in proceeds of $884,520. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.38K
0% 3M change
10.83% 12M change
Total Value Held $1.56 Million

Bonnie L Bassler Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 15 2024
SELL
Open market or private sale
$884,520 $1170.0 p/Share
756 Reduced 35.36%
1,382 Common Stock
Aug 15 2024
BUY
Exercise of conversion of derivative security
$280,778 $371.4 p/Share
756 Added 26.12%
2,138 Common Stock
Aug 02 2024
SELL
Open market or private sale
$842,940 $1115.0 p/Share
756 Reduced 35.36%
1,382 Common Stock
Aug 02 2024
BUY
Exercise of conversion of derivative security
$280,778 $371.4 p/Share
756 Added 26.12%
2,138 Common Stock
Jun 24 2024
SELL
Open market or private sale
$802,872 $1062.0 p/Share
756 Reduced 35.36%
1,382 Common Stock
Jun 24 2024
BUY
Exercise of conversion of derivative security
$280,778 $371.4 p/Share
756 Added 26.12%
2,138 Common Stock
Jun 05 2024
SELL
Open market or private sale
$836,097 $1011.0 p/Share
827 Reduced 37.44%
1,382 Common Stock
Jun 05 2024
BUY
Exercise of conversion of derivative security
$315,045 $380.95 p/Share
827 Added 27.24%
2,209 Common Stock
Feb 26 2024
SELL
Open market or private sale
$836,279 $979.25 p/Share
854 Reduced 38.19%
1,382 Common Stock
Feb 26 2024
BUY
Exercise of conversion of derivative security
$334,699 $391.92 p/Share
854 Added 27.64%
2,236 Common Stock
Jan 30 2024
SELL
Open market or private sale
$793,093 $959.0 p/Share
827 Reduced 37.44%
1,382 Common Stock
Jan 30 2024
BUY
Exercise of conversion of derivative security
$315,045 $380.95 p/Share
827 Added 27.24%
2,209 Common Stock
Jan 03 2024
SELL
Open market or private sale
$754,964 $914.0 p/Share
826 Reduced 37.41%
1,382 Common Stock
Jan 03 2024
BUY
Exercise of conversion of derivative security
$314,664 $380.95 p/Share
826 Added 27.22%
2,208 Common Stock
Jan 02 2024
BUY
Grant, award, or other acquisition
-
135 Added 8.9%
1,382 Common Stock
Dec 13 2023
SELL
Open market or private sale
$530,700 $870.0 p/Share
610 Reduced 32.85%
1,247 Common Stock
Dec 13 2023
BUY
Exercise of conversion of derivative security
$229,780 $376.69 p/Share
610 Added 24.73%
1,857 Common Stock
Aug 21 2023
SELL
Open market or private sale
$707,137 $829.0 p/Share
853 Reduced 40.62%
1,247 Common Stock
Aug 21 2023
BUY
Exercise of conversion of derivative security
$334,307 $391.92 p/Share
853 Added 28.89%
2,100 Common Stock
Aug 10 2023
SELL
Open market or private sale
$673,017 $789.0 p/Share
853 Reduced 40.62%
1,247 Common Stock
Aug 10 2023
BUY
Exercise of conversion of derivative security
$334,307 $391.92 p/Share
853 Added 28.89%
2,100 Common Stock
Mar 24 2023
SELL
Open market or private sale
$1,014,320 $818.0 p/Share
1,240 Reduced 49.86%
1,247 Common Stock
Mar 24 2023
BUY
Exercise of conversion of derivative security
$472,378 $380.95 p/Share
1,240 Added 33.27%
2,487 Common Stock
Feb 03 2023
SELL
Open market or private sale
$795,359 $779.0 p/Share
1,021 Reduced 45.02%
1,247 Common Stock
Feb 03 2023
BUY
Exercise of conversion of derivative security
$388,949 $380.95 p/Share
1,021 Added 31.04%
2,268 Common Stock

Also insider at

RPRX
Royalty Pharma plc Healthcare
CDTX
Cidara Therapeutics, Inc. Healthcare
KLDO
Kaleido Biosciences, Inc. Healthcare
BLB

Bonnie L Bassler

Director
Tarrytown, NY

Track Institutional and Insider Activities on REGN

Follow REGENERON PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells REGN shares.

Notify only if

Insider Trading

Get notified when an Regeneron Pharmaceuticals, Inc. insider buys or sells REGN shares.

Notify only if

News

Receive news related to REGENERON PHARMACEUTICALS, INC.

Track Activities on REGN